TI
SCPH

Trexquant Investment’s scPharmaceuticals SCPH Stock Holding History

Trexquant Investment’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-13,995
Closed -$60.9K – 1823
2024
Q2 		$60.9K Buy
+13,995
New +$61.5K ﹤0.01% 1480
2023
Q1 		– Sell
-14,964
Closed -$107K – 1731
2022
Q4 		$107K Buy
+14,964
New +$91.4K ﹤0.01% 1314
2020
Q4 		– Sell
-11,087
Closed -$83K – 1438
2020
Q3 		$83K Sell
11,087
-14,886
-57% -$116K 0.01% 1145
2020
Q2 		$191K Buy
25,973
+9,293
+56% +$81.6K 0.01% 1057
2020
Q1 		$123K Buy
+16,680
New +$121K 0.01% 1030

Other funds holding SCPH

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JGC
J. Goldman & Co New York $2.16B AUM 33.8% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return